Sofia Tablet 10mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate
Prescription medication
Korea PMG Pharmaceutical Co., Ltd.
MFDS item code 201307918 · Approved 2013.06.28
This product's status changed to Approval withdrawn on 2023.04.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improves hyperlipidemia (including familial hyperlipidemia); prevents cardiovascular diseases (such as myocardial infarction and stroke)
This medication is used to treat various cardiovascular diseases and hyperlipidemia. Firstly, it effectively reduces the risks of myocardial infarction and stroke in adults with multiple risk factors or in patients with type 2 diabetes. Additionally, it helps improve heart health by lowering the risks of myocardial infarction, stroke, angioplasty, and angina in patients with coronary artery disease and decreases the risk of hospitalization due to congestive heart failure. Regarding hyperlipidemia, it decreases LDL cholesterol and total cholesterol while increasing HDL cholesterol to regulate blood lipid levels. It also acts effectively as an adjunct to dietary therapy in patients with familial hypercholesterolemia or among pediatric patients who meet specific criteria. Thus, this medication is used to reduce the risks associated with cardiovascular diseases and improve dyslipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The drug may be taken at any time of day, with or without food. The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring greater reductions in LDL cholesterol may start with 20 mg or 40 mg once daily (the 40 mg starting dose is for patients requiring an LDL cholesterol reduction of more than 45%). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or, if such treatments are unavailable, as monotherapy. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.
This medication may cause muscle-related symptoms, so if there is severe muscle pain or weakness, or a significant increase in creatine kinase levels, discontinue use immediately and consult a doctor. Patients with impaired liver function should not take this medication and should undergo regular liver function tests. Women who are pregnant, may become pregnant, or are nursing should not take this medication. Patients with a history of alcohol abuse or liver disease should use this medication with caution and adjust the dose under medical supervision if necessary. This medication may interact with other drugs, so it is essential to consult a doctor or pharmacist before taking it with certain antibiotics, antifungals, antivirals, some heart medications, antihypertensives, and antidiabetics. Children and individuals under the age of 10 should not take this medication, and long-term safety in adolescents under 18 is not established. Elderly patients are at higher risk for myopathy, so caution is needed during use, and any symptoms should be reported to healthcare providers immediately. In case of overdose, there is no specific antidote, and treatment should be symptomatic while closely monitoring for liver function and muscle damage. Taking this medication with grapefruit juice may increase blood levels of the drug, so it is advisable to avoid grapefruit juice. If symptoms such as muscle pain, weakness, fatigue, or fever occur during use, contact a doctor immediately for evaluation. This medication contains lactose, so patients with lactose intolerance should not take it. Keep this medication out of the reach of children and store it securely in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Doing so will help preserve the medication's effectiveness and prevent degradation.
White, round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Hydrate
Prescription medication
Korea PMG Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.